Voyager Therapeutics Inc (NASDAQ:VYGR)
| 6.06 BATS BZX Real-Time Price As of 10:50am ET |  -0.70 / -10.36%Today’s Change | 2.46 Today|||52-Week Range 10.60 | +123.62% Year-to-Date |
Latest VYGR News | Press Releases
No recent news for Voyager Therapeutics Inc.
Today’s Trading
| Previous close | 6.76 |
| Today’s open | 6.49 |
| Day’s range | 6.06 - 6.60 |
| Volume | 1,255 |
| Average volume (3 months) | 234,537 |
| Market cap | $215.7M |
Data as of 10:50am ET, 09/29/2022
Growth & Valuation
| Earnings growth (last year) | -291.02% |
| Earnings growth (this year) | +5.59% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -78.14% |
| P/E ratio | NM |
| Price/Sales | 2.73 |
| Price/Book | 2.23 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SELBSelecta Biosciences ... | -0.10 | -6.10% |
| ---- | ||
| OTLKOutlook Therapeutics... | 0.00 | 0.00% |
| ---- |
Data as of 10:43am ET, 09/29/2022
Financials
| Next reporting date | November 2, 2022 |
| EPS forecast (this quarter) | -$0.41 |
| Annual revenue (last year) | $37.4M |
| Annual profit (last year) | -$71.2M |
| Net profit margin | -190.29% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
